Published in Cancer Chemother Pharmacol on January 01, 1999
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Aberrant subcellular localization of BRCA1 in breast cancer. Science (1995) 3.61
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. J Clin Oncol (2004) 3.56
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol (2005) 2.88
Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg (1999) 2.68
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res (2000) 1.86
Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. J Natl Cancer Inst (1999) 1.75
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem (1990) 1.66
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem (1989) 1.58
[Exposure of French emergency medical personnel to violence]. Ann Fr Anesth Reanim (2002) 1.55
In situ split liver transplantation for two adult recipients. Transplantation (2000) 1.53
Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol Pharmacol (1998) 1.50
A quality control program for acute pain management in out-of-hospital critical care medicine. Ann Emerg Med (1999) 1.44
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res (1995) 1.44
Local soft tissue toxicity following cisplatin extravasation. J Natl Cancer Inst (1990) 1.42
Delirium in older people after proximal femoral fracture repair: role of a preoperative screening cognitive test. Ann Fr Anesth Reanim (2013) 1.40
A comparison study of two methods of peanut agglutinin staining with S100 immunostaining in 29 cases of histiocytosis X (Langerhans' cell histiocytosis) Arch Pathol Lab Med (1990) 1.40
Possible underestimation of the relative incidence of anaphylactic reactions to benzylisoquinoline neuromuscular blocking agents. Eur J Anaesthesiol (2003) 1.38
Anaesthetic management of patients with phaeochromocytoma. Br J Anaesth (1984) 1.34
Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst (1992) 1.33
Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans. Anesth Analg (1986) 1.31
Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease. Chest (1993) 1.25
Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer (1992) 1.24
Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Clin Cancer Res (1999) 1.23
Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit. Ann Fr Anesth Reanim (2011) 1.22
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res (1996) 1.22
Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth (2007) 1.20
Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes. Am J Transplant (2011) 1.15
Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice. Invest New Drugs (1997) 1.12
Smokeless tobacco use and attitudes toward smokeless tobacco among Native Americans and other adolescents in the northwest. Am J Public Health (1988) 1.11
Survival after first recurrence of breast cancer. The Miami experience. Cancer (1992) 1.05
Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology (1990) 1.05
Investigation of taxol as a potential radiation sensitizer. Cancer (1993) 1.05
Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer. J Clin Oncol (1999) 1.04
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. Ann Oncol (2011) 1.04
Lipid peroxidation as cause of nigral cell death in Parkinson's disease. Lancet (1986) 1.03
Plasma amino acid levels and development of hepatic gluconeogenesis in the newborn rat. Am J Physiol (1975) 0.99
An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol (1997) 0.99
Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101). Cancer Invest (1987) 0.98
Absorption and metabolism of the volatile fatty acids in the hind-gut of the rabbit. Br J Nutr (1984) 0.97
Evaluation of the provision of rapid drug plasma assays in an outpatient anticonvulsant clinic. Ther Drug Monit (1981) 0.96
Techniques, hemodynamic monitoring, and indications for vascular clamping during liver resections. J Hepatobiliary Pancreat Surg (1998) 0.95
Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer (1995) 0.95
Absorption of electrolytes and volatile fatty acids in the hind-gut of the rabbit. Circadian rhythm of hind-gut electrolytes and plasma aldosterone. Br J Nutr (1984) 0.95
Amphibian micronucleus test in vivo: evaluation of the genotoxicity of some major polycyclic aromatic hydrocarbons found in a crude oil. Mutagenesis (1995) 0.95
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin. Invest New Drugs (1999) 0.94
Value of coronary arteriography in the investigation of ischaemic heart disease. Br Heart J (1966) 0.94
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res Treat (2012) 0.94
Cardiovascular responses to manual dissection associated with transhiatal esophageal resection. J Cardiothorac Anesth (1990) 0.93
Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg (2001) 0.93
Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest (1995) 0.93
Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. Clin Cancer Res (2001) 0.93
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. Invest Ophthalmol Vis Sci (1998) 0.92
Lung carcinoma in 1,336 patients. Am J Clin Oncol (1991) 0.91
Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med (2001) 0.91
Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob Agents Chemother (1999) 0.90
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet (1996) 0.90
Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice. Int J Cancer (1985) 0.90
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat (2011) 0.90
Tacrolimus clearance is age-dependent within the pediatric population. Bone Marrow Transplant (2000) 0.89
Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors. Cancer Chemother Pharmacol (2013) 0.89
A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice. J Natl Cancer Inst (1984) 0.89
Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs (1997) 0.89
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Clin Cancer Res (2000) 0.89
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity. Clin Cancer Res (1997) 0.89
Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum Pathol (1988) 0.89
Continuous epidural infusion of ropivacaine for postoperative analgesia after major abdominal surgery: comparative study with i.v. PCA morphine. Br J Anaesth (1998) 0.88
Phase I pharmacokinetic study of the novel antitumor agent SR233377. Clin Cancer Res (2000) 0.88
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients. Ann Oncol (2001) 0.88
Elevated expression of DNA ligase I in human cancers. Clin Cancer Res (2001) 0.87
Prolymphocytic transformation of chronic lymphocytic leukemia. Cancer (1981) 0.87
Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam. Anesth Analg (1995) 0.86
[Variations in the course of the inferior laryngeal nerve. Surgical anatomy, classification, diagnosis]. Chirurg (2004) 0.86
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant (2003) 0.86
[Results of resection treatment of chronic pancreatitis (author's transl)]. Dtsch Med Wochenschr (1977) 0.85
Remifentanil sedation compared with propofol during regional anaesthesia. Acta Anaesthesiol Scand (2002) 0.85
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. Cancer Res (1999) 0.85
Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Res (1998) 0.85
Increased rate of sealing in beating heart muscle of the toad. Circ Res (1970) 0.85
A comparative analysis of the phenotypic characteristics of available fusion partners for the construction of human hybridomas. Hybridoma (1983) 0.85
Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochem Pharmacol (1995) 0.84
The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. Clin Cancer Res (2000) 0.84
A phase I trial of taxol given by a 6-hour intravenous infusion. J Clin Oncol (1991) 0.84
Intraoperative pacemaker-mediated tachycardia: a complication of dual-chamber cardiac pacemakers. Anesthesiology (1993) 0.84
Effects of midazolam on the coronary circulation in patients with coronary artery disease. Anesthesiology (1986) 0.84
Intraoperative pacemaker malfunction during a shoulder arthroscopy. Anesthesiology (2000) 0.83
Effects of exogenous hormones and glucose on plasma levels and hepatic metabolism of amino acids in the fetus and in the newborn rat. Diabetologia (1976) 0.83
Recovery of HIV at autopsy. N Engl J Med (1989) 0.83
Paradoxical air embolism during orthoptic liver transplantation: diagnosis by transoesophageal echocardiography. Eur J Anaesthesiol (1999) 0.83
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts. Cancer Res (1999) 0.82
Guidelines for perioperative cardiac evaluation from the American College of Cardiology/American Heart Association task force are effective for stratifying cardiac risk before aortic surgery. J Vasc Surg (2000) 0.82
[Rupture of a thoracic aortic aneurysm into the right pleural cavity]. Ann Fr Anesth Reanim (2006) 0.82